Federal award (DEFINITIVE CONTRACT, fiscal year 2024)
Recipient: RIPTIDE THERAPEUTICS LLC
Awarding agency: Department of Health and Human Services / National Institutes of Health
Funding agency: Department of Health and Human Services / National Institutes of Health
Period of performance: 2023-09-25 to 2026-01-31
Current total value of award: $400000
Description: FY23 PHASE I SBIR TOPIC 446